Cargando…

Activin Receptor-Like Kinase 5 Inhibitor Attenuates Fibrosis in Fibroblasts Derived from Peyronie's Plaque

PURPOSE: Transforming growth factor-β1 (TGF-β1) is the key fibrogenic cytokine associated with Peyronie's disease (PD). The aim of this study was to determine the antifibrotic effect of 3-((5-(6-Methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl) methyl)benzamide (IN-1130), a small-molecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Jin Hyuk, Ryu, Ji Kan, Suh, Jun Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272556/ https://www.ncbi.nlm.nih.gov/pubmed/22323974 http://dx.doi.org/10.4111/kju.2012.53.1.44

Ejemplares similares

Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease
por: Song, Kang-Moon, et al.
Publicado: (2020)

AB083. TEW-7197, a novel orally bioavailable activin receptor-like kinase 5 inhibitor, promotes regression of fibrotic plaque in a rat model of Peyronie’s disease
por: Song, Kang-Moon, et al.
Publicado: (2018)

Effect of SMAD7 gene overexpression on TGF-β1-induced profibrotic responses in fibroblasts derived from Peyronie's plaque
por: Choi, Min Ji, et al.
Publicado: (2015)

Silencing Histone Deacetylase 7 Alleviates Transforming Growth Factor-β1-Induced Profibrotic Responses in Fibroblasts Derived from Peyronie's Plaque
por: Kang, Dong Hyuk, et al.
Publicado: (2018)

Kaempferol attenuates liver fibrosis by inhibiting activin receptor–like kinase 5
por: Xu, Taifu, et al.
Publicado: (2019)

Activin–like kinase–3 activity is important for kidney regeneration and reversal of fibrosis
por: Sugimoto, Hikaru, et al.
Publicado: (2012)

Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor
por: Sapitro, Jennifer, et al.
Publicado: (2010)

Multiple plaque incisions with or without grafting for Peyronie's disease
por: Hegarty, Paul K., et al.
Publicado: (2022)

The orphan ligand, activin C, signals through activin receptor-like kinase 7
por: Goebel, Erich J, et al.
Publicado: (2022)

Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting
por: Levolger, S., et al.
Publicado: (2019)

RNA-sequencing profiling analysis of pericyte-derived extracellular vesicle–mimetic nanovesicles-regulated genes in primary cultured fibroblasts from normal and Peyronie’s disease penile tunica albuginea
por: Yin, Guo Nan, et al.
Publicado: (2021)

Sonographic patterns of Peyronie's disease in patients with absence of palpable plaques
por: Dell'Atti, Lucio, et al.
Publicado: (2018)

The Outcome of Multiple Slit on Plaque with Plication Technique for the Treatment of Peyronie's Disease
por: Shin, Su Hwan, et al.
Publicado: (2016)

Ultrasound on Erect Penis Improves Plaque Identification in Patients With Peyronie’s Disease
por: Liu, Yu, et al.
Publicado: (2019)

An Activin Receptor IA/Activin-Like Kinase-2 (R206H) Mutation in Fibrodysplasia Ossificans Progressiva
por: Herrera-Esparza, Rafael, et al.
Publicado: (2013)

The Activin Receptor, Activin-Like Kinase 4, Mediates Toxoplasma Gondii Activation of Hypoxia Inducible Factor-1
por: Lis, Agnieszka, et al.
Publicado: (2019)

Activin E is a TGFβ ligand that signals specifically through activin receptor-like kinase 7
por: Vestal, Kylie A, et al.
Publicado: (2023)

Review of the Surgical Approaches for Peyronie's Disease: Corporeal Plication and Plaque Incision with Grafting
por: Tran, Viet Q., et al.
Publicado: (2008)

Twenty Years of Plaque Incision and Grafting for Peyronie’s Disease: A Review of Literature
por: Rice, Patrick G., et al.
Publicado: (2019)

Flavones hydroxylated at 5, 7, 3′ and 4′ ameliorate skin fibrosis via inhibiting activin receptor-like kinase 5 kinase activity
por: Zhang, Yifan, et al.
Publicado: (2019)

Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis
por: Kasam, Rajesh K, et al.
Publicado: (2020)

Perspectives of small molecule inhibitors of activin receptor-like kinase in anti-tumor treatment and stem cell differentiation
por: Cui, Xueling, et al.
Publicado: (2019)

A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
por: Imakura, Takeshi, et al.
Publicado: (2023)

AB082. The outcome of multiple slit on plaque with plication technique for the treatment of Peyronie’s disease
por: Kang, Jae Il, et al.
Publicado: (2016)

Role of activin receptor-like kinase 1 in vascular development and cerebrovascular diseases
por: Hong, Jun-Mou, et al.
Publicado: (2020)

Targeting heterotopic ossification by inhibiting activin receptor-like kinase 2 function
por: Shi, Fuli, et al.
Publicado: (2019)

Inhibitors of Activin Receptor-like Kinase 5 Interfere with SARS-CoV-2 S-Protein Processing and Spike-Mediated Cell Fusion via Attenuation of Furin Expression
por: Mezger, Maja C., et al.
Publicado: (2022)

The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology
por: Hardy, Charles L, et al.
Publicado: (2015)

Activin B signaling may promote the conversion of normal fibroblasts to scar fibroblasts
por: Deng, Shi-Kang, et al.
Publicado: (2020)

Excision and Patch Grafting of a Lateral Peyronie’s Plaque—Utilizing a Longitudinal “Window” Approach
por: Lue, Kathy, et al.
Publicado: (2015)

Combined Plaque Incision, Buccal Mucosa Grafting, and Additional Tunica Albuginea Plication for Peyronie’s Disease
por: Cormio, Luigi, et al.
Publicado: (2018)

3D-Printed Flexible Penile Model Simulator for Plaque Incision and Graft for Peyronie's Disease
por: Miranda, Alexandre
Publicado: (2021)

Disappearance of Plaque Following Treatment with Antioxidants in Peyronie’s Disease Patients—A Report of 3 Cases
por: Paulis, Gianni, et al.
Publicado: (2022)

HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis
por: Son, Mi Kwon, et al.
Publicado: (2013)

Bioinformatic Analysis of Pathogenic Missense Mutations of Activin Receptor Like Kinase 1 Ectodomain
por: Scotti, Claudia, et al.
Publicado: (2011)

Activin-Like Kinase 2 Functions in Peri-implantation Uterine Signaling in Mice and Humans
por: Clementi, Caterina, et al.
Publicado: (2013)

Targeting activin receptor–like kinase 7 ameliorates adiposity and associated metabolic disorders
por: Zhao, Min, et al.
Publicado: (2023)

Endothelial Activin Receptor-Like Kinase 1 (ALK1) Regulates Myofibroblast Emergence and Peritubular Capillary Stability in the Early Stages of Kidney Fibrosis
por: Martínez-Salgado, Carlos, et al.
Publicado: (2022)

The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts
por: Diller, Magnus, et al.
Publicado: (2019)

Activin B promotes the initiation and progression of liver fibrosis
por: Wang, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j69dprvgvjosha4l9irenj5c9b